Trial of Cervical Ripening and Labor Induction Using Misoprostol With or Without Intravaginal Isosorbide Mononitrate
Information source: Stanford University
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cervical Ripening
Intervention: isosorbide mononitrate (Drug)
Phase: N/A
Status: Active, not recruiting
Sponsored by: Stanford University Official(s) and/or principal investigator(s):
Yasser Yehia El-Sayed, Principal Investigator, Affiliation: Stanford University
Summary
The purpose of this study is to determine the efficacy and safety of the addition of
intravaginal isosorbide mononitrate to an established protocol of oral misoprostol for
cervical ripening and labor induction.
Clinical Details
Official title: Randomized Clinical Trial of Cervical Ripening and Labor Induction Using Stepwise Oral Misoprostol With or Without Intravaginal Isosorbide Mononitrate
Study design: Randomized, Open Label, Active Control, Single Group Assignment
Primary outcome: Time to vaginal delivery
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Female.
Criteria:
Inclusion Criteria::
- Pregnant women
- 18 years of age or greater
- Singleton pregnancy between 32-42 weeks gestation requiring labor induction
- Membranes must be intact Exclusion Criteria:- Ruptured membranes
- Gestational age less than 32 weeks
- Non-reassuring fetal heart rate tracing
Locations and Contacts
Stanford University School of Medicine, Stanford, California 94305, United States
Additional Information
Last updated: May 7, 2008
|
